Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy

Area of Science:

• Hepatology
• Neurology
• Clinical Medicine

Background:

• Hepatic encephalopathy (HE) is a severe complication of liver disease, causing significant patient morbidity and mortality.
• Managing hospitalized patients with HE presents increasing complexity and economic burden.
• Accurate diagnosis of HE, especially covert HE (CHE), remains a significant clinical challenge.

Purpose of the Study:

• To review novel and emerging diagnostic tools for covert HE (CHE).
• To summarize the latest advancements in managing overt HE (OHE) and CHE, both acutely and long-term.
• To present current data on established and adjunctive therapeutic agents.

Main Methods:

• Literature review of recent studies and clinical trials.
• Analysis of diagnostic modalities for CHE.
• Evaluation of evidence for pharmacological interventions in OHE and CHE.

Main Results:

• New diagnostic tools for CHE are under development.
• Lactulose and rifaximin remain key treatments for OHE.
• Adjunctive therapies like sodium benzoate and probiotics show potential.

Conclusions:

• Improved diagnostic strategies for CHE are needed.
• Current management of OHE and CHE relies on established and emerging pharmacological options.
• Further research into adjunctive therapies may enhance HE patient outcomes.